Clinical Cases from the STD Clinical Consultation Network

Similar documents
Disclosures. STD Screening for Women. Chlamydia & Gonorrhea. I have no disclosures or conflicts of interest to report.

ALASKA NATIVE MEDICAL CENTER SEXUALLY TRANSMITTED DISEASE SCREENING AND TREATMENT GUIDELINES

Stephanie. STD Diagnosis and Treatment. STD Screening for Women. Physical Exam. Cervix with discharge from os

STI 2016: Where We Need to Go

Answers to those burning questions -

The (likely) New 2010 CDC STD Treatment Guidelines Guideline Development Process. Overview

Khalil G. Ghanem, MD, PhD Associate Professor of Medicine Johns Hopkins University School of Medicine. April 2, 2014

Sexually Transmitted Diseases. Summary of CDC Treatment Guidelines

Sexually transmitted infections (in women)

STDs and Hepatitis C

Update on Sexually Transmitted Infections among Persons Living with HIV

Sexually transmitted infections (in women)

Nothing to disclose.

Edward W. Hook, III, M.D.

Update on Sexually Transmitted Infections Jeanne Marrazzo, MD, MPH

Sexually Transmitted Infections: New Tests, New Guidelines

STI Indicators by STI

Categories of STI Screening and Testing Routine screening Population based risk factors Targeted screening Personal behavioral risk factors Contact te

S403- Update on STIs for the Generalists

Clinical Practice Objectives

Sexually Transmitted Diseases

Chapter 11. Sexually Transmitted Diseases

Best Practices in STD Partner Management

STD Essentials for the Busy Clinician. Stephanie E. Cohen, MD, MPH

Challenging STD Cases. Chris Davis, PA-C University of Utah Clinic 1A

Genital Herpes in the STD Clinic

TO DECREASE THE CHANCE OF GETTING

Sexually Transmitted Disease Treatment Tables

STDs in HIV Clinical Care: New Guidelines on Treatment and Prevention

Novos desafios para controlar as infecções sexualmente transmissíveis [New Challenges in Managing Sexually Transmitted Infections]

New Guidelines for Detection and Treatment of Sexually Transmitted Infections

RETURN OF THE CLAP: Emerging Issues in Gonorrhea Management and Antibiotic Resistance

Sexually Transmitted Infections in the Adolescent Population. Abraham Lichtmacher MD FACOG Chief of Women s Services Lovelace Health System

Trends in Sexually Transmitted Infections (STIs) C. Junda Woo, MD, MPH, Medical Director San Antonio Metropolitan Health District June 3, 2017

STI Treatment Guidelines. Teodora Wi. Training Course in Sexual and Reproductive Health Research

Timby/Smith: Introductory Medical-Surgical Nursing, 9/e

The Great Imitator Revealed: Syphilis

A Man with a Rash and Pink Eye. STD Case Studies from the Denver Metro Health Clinic

Overview. Disclosures. Sexually Transmitted Diseases: What s New in the Guidelines and Beyond?

Extragenital Gonorrhea and Chlamydia among MSM

STD UPDATE 2017 FSACOFP CONVENTION

Management of Syphilis in Patients with HIV

CLINICAL MANAGEMENT OF STDS

Sexually Transmitted Diseases:

5/1/2017. Sexually Transmitted Diseases Burning Questions

One week of doxycycline is an effective treatment for asymptomatic rectal Chlamydia trachomatis infection

INTRAUTERINE DEVICES AND INFECTIONS. Tips for Evaluation and Management

Syphilis: Screening (USPSFT) Syphilis: Screening. Sexually Transmitted Diseases. Family Medicine Board Review Course. Reference

Emerging Issues in STDs and Resistance

People with genital herpes require enough information and medication (when indicated) to self-manage their condition.

Services for GLBTQ Youth

6/11/15. BACTERIAL STDs IN A POST- HIV WORLD. Learning Objectives. How big a problem are STIs in the U.S.?

Michigan Guidelines: HIV, Syphilis, HBV in Pregnancy

MYCOPLASMA GENITALIUM A PRACTICAL GUIDE

2/17/2017. Sexually Transmitted Diseases in Children: Is it Abuse? General Considerations. Judy Guinn, MD WI CAN Educational Series February 17, 2017

Family Planning Title X Chlamydia Screening Quality Improvement Project

3/28/2016. Why you should care? Dana W. Dunne, MD, FACP Associate Professor of Medicine Yale University School of Medicine New Haven, Connecticut

STIs: Practical Aspects of Management

EHIVQUAL. For use with ehivqual, an electronic web based program for quality of care data collection and review REVIEW PERIOD:

9/9/2015. Began to see a shift in 2012 Early syphilis cases more than doubled from year before

2015 CDC STD GUIDELINES: NEW TESTING, TREATMENT AND DISEASE

Gonococcal Infection- Treatment Consideration

Drugs for UTIs and STDs. Dr.Vishaal Bhat Associate Professor MMMC Manipal

Antivirals and Vaccines: What s old and new in HSV-2 treatment

4/6/17 UNPRECEDENTED HIGH. Shelagh Larson, RNC, WHNP, NCMP

Behaviors Associated with Changes in The Vaginal Microbiome

toe... Chlamydia - CDC Fact Sheet Appendix K - Part 2

Treatment of Refractory Trichomoniasis

Didactic Series. STD Screening & Management: Syphilis. Christian B. Ramers, MD, MPH

Genital Tract Infections in Women. Michael S. Policar, MD, MPH UCSF School of Medicine

Dr Selena Singh. Guy s and St Thomas NHS Foundation Trust, London THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014

Dermatologist Venereologist MD, PhD

Sexually Transmitted Infections in HSV-2 Seropositive women in Sub- Saharan Africa HPTN 039

SEXUALLY TRANSMITTED DISEASES TREATMENT GUIDELINES (Part 1 of 5)

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE OBJECTIVES FOR PHARMACISTS GOAL

Population attributable fraction of genital inflammation and ulceration in HIV risk among discordant couples, Zambia,

Genital Chlamydia and Gonorrhea Epidemiology, Diagnosis, and Management. William M. Geisler M.D., M.P.H. University of Alabama at Birmingham

STI/HIV Update 6/7/2018. Objectives. Chlamydia

Disclosures. What s New in the 2015 CDC STD Treatment Guidelines. Outline. None

Syphilis Treatment Protocol

Women s Sexual Health: STI and HIV Screening. Barbara E. Wilgus, MSN, CRNP STD/HIV Prevention Training Center at Johns Hopkins

Practice Steps for Implementation of Guidelines Recommendations The guideline recommendations are shown schematically -

How to Prevent Sexually Transmitted Diseases

WHAT DO U KNOW ABOUT STIS?

Learning Objectives. STI Update. Case 1 6/1/2016

Syphilis Update: New Presentations of an Old Disease

Trends in STDs: US Perspective. Michael Towns, M.D. WW Vice President, Medical Affairs BD Diagnostic Systems

What You Need to Know. Sexually Transmitted Infections (STIs)

DECISION SUPPORT TOOL FOR RN SANES DISPENSING PROPHYLAXIS FOR SEXUALLY TRANSMITTED INFECTION AFTER SEXUAL ASSAULT

HOT OFF THE PRESS! R.

- Polyurethane condoms comparable to latex. - Natural (i.e. Lamb Skin) - Pores 10x > diameter of HIV virus; 25x > diameter Hep B

Shelagh Larson, RNC, WHNP, NCMP

5/12/11. STI s in Adolescents: Exposing the Hidden Epidemic. Why the hidden epidemic?

X-Treme Primary Care: HPV and STIs. Arti Barnes MD MPH Clinical Director South Central AIDS Education and Training Centers

10/29/2018 PROPHYLAXIS AND TREATMENT: CURBING THE ALARMING SPREAD OF SEXUALLY TRANSMITTED DISEASES DISCLOSURE GOAL

The Impact of Sexually Transmitted Diseases(STD) on Women

What Bugs You? A Sexually Transmitted Infection Review

Sexually Transmitted Diseases

Ron Gray, MBBS, MFCM, MSc Johns Hopkins University. STIs in an International Setting

Outline. HIV and Other Sexually Transmitted Infections. Gonorrhea Epidemiology. Epidemiology 11/2/2012

Transcription:

Clinical Cases from the STD Clinical Consultation Network Christine Johnston STD TCG April 24, 2017 Last Updated: uwptc@uw.edu uwptc.org 206-685-9850

STD Clinical Consultation Network (STDCCN) Developed by Denver PTC Launched in June 2015 Provides STD clinical consultation services within 1-3 business days, depending on urgency, to healthcare providers nationally Your consultation request is linked to your regional PTC s expert faculty We are just a click away! www.stdccn.org

Case 1: Timing of ceftriaxone/azithromycin administration QUESTION: The gonorrhea treatment of ceftriaxone and azithromycin is meant to be given simultaneously. If patients are treated with azithromycin prior to receiving a positive gonorrhea test result, do you recommend retreating with azithromycin plus ceftriaxone vs administering ceftriaxone alone?

Case 1: Timing of ceftriaxone/azithromycin administration 1. Treat with azithromycin/ceftriaxone if >7 days since azithromycin was administered 2. Treat with ceftriaxone alone regardless of timing of azithromycin dosing 3. Treat with ceftriaxone alone if <=5 days since azithromycin was administered 4. Treat with both drugs regardless of timing of azithromycin dosing

Case 1: CTX/Azithromycin timing Gray areas: Question and answers for the 2015 CDC Guidelines - https://www.cdc.gov/std/tg2015/qa/default.htm The half-life of azithromycin is long (68 hours). - It is probably safe to administer ceftriaxone within five days of the azithromycin dose. The half-life of ceftriaxone is short (6 9 hours). - Patients should be retreated with both drugs if they fail to take azithromycin when they receive the ceftriaxone injection. https://www.cdc.gov/std/tg2015/qa/default.htm

Case 2: Vaginal seeding Pt who might end up with a C/S for breech, she is interested in vaginal seeding. She is HSV-2 positive and taking prophylaxis as prescribed (acyclovir 400 mg PO TID). Do you think vaginal seeding is a good idea for her if she is GBS negative?

Case 2: Vaginal seeding Association between C-sections and increased risk for obesity, asthma, allergies and immune deficiencies Babies born via C-section are colonized with skin microbiome, rather than vaginal microbiome Study: 4 patients underwent microbial restoration procedure Incubate gauze in vaginal secretions for 60 minutes Within 2 minutes of birth, put gauze in mouth of infant, then swab entire face and skin Partially restored colonization with vaginal microbiome (compared with 7 infants who underwent vaginal birth and 7 who underwent C-section Increasing popularity of this practice among patients, despite unknown risks or benefits Dominguez-Bello et al, Nat Med 2016

Case 2: Do you recommend vaginal seeding? 1. Yes 2. No

Case 2: Vaginal seeding: Answer There are no data regarding risks of HSV transmission with vaginal seeding in women with a history of genital herpes. There have been cases of transmission of neonatal herpes among women receiving suppressive therapy, suggesting that breakthrough shedding can occur. Lack of data regarding benefit of vaginal seeding and the risks for possible HSV transmission. Given that potential harm outweighs unknown benefit, would strongly advise against vaginal seeding. Pinninti J Pedatrics 2012

Case 3: Dosing of azithromycin QUESTION: A 22 year old female with a positive vaginal chlamydia test was treated with a Z-pack as an oversight: 500 mg azithromycin day 1, 250 mg per day days 2-5. Would this schedule achieve adequate concentration of med? Does she need treatment with azithromycin 1 gm?

Case 3: Dosing of azithromycin 1. Redose with azithromycin 1 gm PO x 1 2. Do not redose. Her treatment was adequate with z-pack. ANSWER: Redose with Azithromycin 1 gm PO x 1. Although it is PROBABLY adequate, re-treat in cases where patients received Z-packs

Case 4: Boric acid toxicity QUESTION: A 25 yo woman with recurrent BV was treated with metronidazole, now using intravaginal boric acid capsules (600 mg) for 21 days to eradicate BV. When is it safe to resume/receive receptive oral sex? ANSWER: 24 hours after the last administration

Case 4: Boric acid toxicity Per Washington Poison Center: - The amount of boric acid in a Type O gelatin capsule is about 600 mg (0.6 g) which is a very low dose The average ingested dose which caused any symptoms at all in humans was 3.2 grams, but it was also highly variable with individual values ranging from 0.1 to 55.5 g). - Even if someone were to ingest the entire capsule, the concern would be for mild mucosal irritation or GI irritation. Treatment: rinse out the mouth only. - Still would always counsel people to wait ~24 hours if possible before engaging in oral sex.

Case 5: Treatment of PID and GC QUESTION: A 25 year old woman received outpatient treatment for PID with cefoxitin 2 gm IV x 1 and doxycycline 100 gm PO BID x 10 days. Test results later returned positive for GC and CT. Should the patient return to receive ceftriaxone +/- azithromycin to treat GC? ANSWER: TOC in 2 weeks

Case 5: PID and GC CDC outpatient PID regimens: Ceftriaxone 250 mg IM* OR-cefoxitin 2 gm IM + probenecid 1 gm PO WITH Doxycycline 100 mg PO BID x 14 days WITH/WITHOUT Metronidazole 500 mg BID x 14 days *or other third generation parenteral cephalosporin 2015 CDC STD Guidelines

Case 5: PID and GC TOC in 2 weeks, including culture/sensis. If the TOC is positive for gonorrhea, we would then recommend retreatment with ceftriaxone 250mg IM and azithromycin 1g PO. Cefoxitin is considered an effective, single-dose injectable to treat gonorrhea when given with probenecid 1g PO. However, she did not receive the recommended first-line or alternative therapy (no probenecid given). If probenecid given, rescreen in 3 months.

Case 6: Rising syphilis titers 46 yo MSM with well controlled HIV infection on ART (VL undetectable, CD4 >500) with previously treated syphilis with negative RPR 2 years ago. - Three months ago had positive RPR with 1:32 dilution. - Asymptomatic. - Received benzathine PCN 2.4 million units q week x3. - He has had 3 anonymous sex partners in the interim, does not use condoms. Now has RPR at 1:512. - Careful neuro ROS/exam is negative - Should he be retested in 3 months, retested now, retreated?

Case 6: Rising syphilis titers 1. Retreat. He is probably reinfected. 2. Perform an LP. He may have CNS invasion from previous infection. 3. Retest in 1-3 months. The increasing titer is delayed response to previously treated infection.

Case 6: Answer Possibilities: - Patient has been reinfected, and has early syphilis - He had CNS invasion which was not cleared with benzathine penicillin.